In this issue
- Choosing First-Line Systemic Therapy for Newly Diagnosed Metastatic Hormone Sensitive Prostate Cancer
- Choosing First-Line Treatment for Metastatic Castration-Resistant Prostate Cancer: APCCC Highlights
- A Review of Comprehensive Bone Health Management Strategies for Men with Prostate Cancer
- Controversies with PSMA-Based Imaging and Targeted Therapy
- Monitoring and Managing Toxicities in Patients with Metastatic Hormone-Sensitive Prostate Cancer
- Spotlight: Advanced Prostate Cancer Consensus Conference 2019
{optin-asset[id:56,label:Download PDF,linkClass:button download]}